Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 153

Related Citations for PubMed (Select 21220533)

1.

Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections.

de Kraker ME, Wolkewitz M, Davey PG, Koller W, Berger J, Nagler J, Icket C, Kalenic S, Horvatic J, Seifert H, Kaasch AJ, Paniara O, Argyropoulou A, Bompola M, Smyth E, Skally M, Raglio A, Dumpis U, Kelmere AM, Borg M, Xuereb D, Ghita MC, Noble M, Kolman J, Grabljevec S, Turner D, Lansbury L, Grundmann H; BURDEN Study Group.

Antimicrob Agents Chemother. 2011 Apr;55(4):1598-605. doi: 10.1128/AAC.01157-10. Epub 2011 Jan 10. Erratum in: Antimicrob Agents Chemother. 2011 Jul;55(7):3646. multiple author names added.

2.

Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus.

Harbarth S, Rutschmann O, Sudre P, Pittet D.

Arch Intern Med. 1998 Jan 26;158(2):182-9.

PMID:
9448557
4.

Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins.

de Kraker ME, Wolkewitz M, Davey PG, Koller W, Berger J, Nagler J, Icket C, Kalenic S, Horvatic J, Seifert H, Kaasch A, Paniara O, Argyropoulou A, Bompola M, Smyth E, Skally M, Raglio A, Dumpis U, Melbarde Kelmere A, Borg M, Xuereb D, Ghita MC, Noble M, Kolman J, Grabljevec S, Turner D, Lansbury L, Grundmann H.

J Antimicrob Chemother. 2011 Feb;66(2):398-407. doi: 10.1093/jac/dkq412. Epub 2010 Nov 23.

5.

Methicillin-resistant Staphylococcus aureus bloodstream infection: risk factors and clinical outcome in non-intensive-care units.

Naves KS, Vaz da Trindade N, Gontijo Filho PP.

Rev Soc Bras Med Trop. 2012 Mar-Apr;45(2):189-93.

6.
7.

Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study.

Hanberger H, Walther S, Leone M, Barie PS, Rello J, Lipman J, Marshall JC, Anzueto A, Sakr Y, Pickkers P, Felleiter P, Engoren M, Vincent JL; EPIC II Group of Investigators.

Int J Antimicrob Agents. 2011 Oct;38(4):331-5. doi: 10.1016/j.ijantimicag.2011.05.013. Epub 2011 Jul 28.

PMID:
21798720
8.

Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections.

Kopp BJ, Nix DE, Armstrong EP.

Ann Pharmacother. 2004 Sep;38(9):1377-82. Epub 2004 Jul 20.

PMID:
15266044
9.
10.

The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges.

Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y.

Infect Control Hosp Epidemiol. 2005 Feb;26(2):166-74.

PMID:
15756888
11.

Nosocomial MRSA infection in vascular surgery patients: impact on patient outcome.

Cowie SE, Ma I, Lee SK, Smith RM, Hsiang YN.

Vasc Endovascular Surg. 2005 Jul-Aug;39(4):327-34.

PMID:
16079941
12.

Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe.

de Kraker ME, Davey PG, Grundmann H; BURDEN study group.

PLoS Med. 2011 Oct;8(10):e1001104. doi: 10.1371/journal.pmed.1001104. Epub 2011 Oct 11.

13.

Impact of traditional hospital strain of methicillin-resistant Staphylococcus aureus (MRSA) and community strain of MRSA on mortality in patients with community-onset S aureus bacteremia.

Chen SY, Wang JT, Chen TH, Lai MS, Chie WC, Chien KL, Hsueh PR, Wang JL, Chang SC.

Medicine (Baltimore). 2010 Sep;89(5):285-94. doi: 10.1097/MD.0b013e3181f1851e.

PMID:
20827105
14.
15.

Burden of meticillin-resistant Staphylococcus aureus infections at a Swiss University hospital: excess length of stay and costs.

Macedo-Viñas M, De Angelis G, Rohner P, Safran E, Stewardson A, Fankhauser C, Schrenzel J, Pittet D, Harbarth S.

J Hosp Infect. 2013 Jun;84(2):132-7. doi: 10.1016/j.jhin.2013.02.015. Epub 2013 Apr 19.

PMID:
23608003
16.

Staphylococcus aureus bacteremia after thermal injury: the clinical impact of methicillin resistance.

Theodorou P, Lefering R, Perbix W, Spanholtz TA, Maegele M, Spilker G, Thamm OC.

Burns. 2013 May;39(3):404-12. doi: 10.1016/j.burns.2012.12.006. Epub 2013 Jan 10.

PMID:
23313016
17.

Healthcare-associated Staphylococcus aureus bloodstream infection: length of stay, attributable mortality, and additional direct costs.

Primo MG, Guilarde AO, Martelli CM, Batista LJ, Turchi MD.

Braz J Infect Dis. 2012 Nov-Dec;16(6):503-9. doi: 10.1016/j.bjid.2012.10.001. Epub 2012 Nov 15.

18.

Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.

Wang JL, Chen SY, Wang JT, Wu GH, Chiang WC, Hsueh PR, Chen YC, Chang SC.

Clin Infect Dis. 2008 Mar 15;46(6):799-806. doi: 10.1086/527389.

19.

Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection.

Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, Briggs JP, Sexton DJ, Kaye KS.

Clin Infect Dis. 2003 Mar 1;36(5):592-8. Epub 2003 Feb 7.

20.

Risk factors for meticillin resistance and outcome of Staphylococcus aureus bloodstream infection in a Belgian university hospital.

Libert M, Elkholti M, Massaut J, Karmali R, Mascart G, Cherifi S.

J Hosp Infect. 2008 Jan;68(1):17-24. Epub 2007 Oct 22.

PMID:
17942190
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk